Por favor, use este identificador para citar o enlazar este ítem:
https://repositorio.uca.edu.ar/handle/123456789/1667
Campo DC | Valor | Lengua/Idioma |
---|---|---|
dc.contributor.author | Pérez Lloret, Santiago | es |
dc.contributor.author | Rey, Verónica | es |
dc.contributor.author | Pavy-Le Traon, Anne | es |
dc.contributor.author | Rascol, Olivier | es |
dc.date.accessioned | 2019-05-02T14:01:20Z | - |
dc.date.available | 2019-05-02T14:01:20Z | - |
dc.date.issued | 2013 | - |
dc.identifier.citation | Pérez Lloret, S., et al. Emerging drugs for autonomic dysfunction in Parkinson's disease [en línea]. Preprint del documento publicado en Expert Opinion on Emerging Drugs. 2013, 18 (1). doi:10.1517/14728214.2013.766168. Disponible en: https://repositorio.uca.edu.ar/handle/123456789/1667 | es |
dc.identifier.uri | https://repositorio.uca.edu.ar/handle/123456789/1667 | - |
dc.description.abstract | Abstract: Autonomic dysfunction, including orthostatic hypotension (OH), sialorrhea, sexual dysfunction, urinary dysfunction and constipation is a common feature of Parkinson’s disease (PD). Even though its treatment has been recognized as a major unmet need in PD, there is a paucity of clinical trials to assess their treatment. Areas covered: Evidence about the efficacy and safety of available treatments for autonomic dysfunction is summarized. Potential targets for upcoming therapies are then discussed in light of what is currently known about the physiopathology of each disorder in PD. Proof-of-concept trials and circumstantial evidence about treatments for autonomic dysfunction as well as upcoming clinical trials are discussed. Finally, critical aspects of clinical trials design are considered. Expert opinion: Botulinum toxin (BTX) or glycopyrrolate might be used for sialorrhea whereas macrogol could be useful in constipation. There is preliminary evidence suggesting that fludrocortisone, domperidone, droxidopa or fipamezole may be effective for the treatment of OH. Tropicamide, clonidine or radiotherapy are under development for sialorrhea. Sildenafil may be effective for the treatment of erectile dysfunction; BTX or behavioral therapy for urinary incontinence and lubiprostone and probiotics for constipation. Sound clinical trials are needed in order to allow firm evidence-based recommendations about these treatments | es |
dc.format | application/pdf | es |
dc.language | eng | es |
dc.language.iso | eng | es |
dc.publisher | Taylor and Francis | es |
dc.rights | Acceso Abierto | es |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-sa/4.0/ | es |
dc.source | Preprint del documento publicado en Expert Opinion on Emerging Drugs, Vol. 18, Nro. 1, 2013 | es |
dc.subject | TOXINA BOTULIMICA | es |
dc.subject | ESTREÑIMIENTO | es |
dc.subject | DOMPERIDONA | es |
dc.subject | DROXIDOPA | es |
dc.subject | DISFUNCION ERECTIL | es |
dc.subject | FLUDROCORTISONA | es |
dc.subject | INCONTINENCIA | es |
dc.subject | HIPOTENSION ORTOSTATICA | es |
dc.subject | ENFERMEDAD DE PARKINSON | es |
dc.subject | DISFUNCION URINARIA | es |
dc.title | Emerging drugs for autonomic dysfunction in Parkinson's disease | es |
dc.type | Artículo | es |
dc.identifier.doi | 10.1517/14728214.2013.766168 | - |
uca.path | Facultad de Ciencias Médicas|Departamento de Docencia e Investigación | es |
uca.disciplina | MEDICINA | es |
uca.filename | /home/data-uca-generic/folder_generic/IIBiomedicas/emerging-drugs-autonomic/metadata.xml | es |
uca.issnrd | 1 | es |
uca.affiliation | Fil: Pérez Lloret, Santiago. Universidad de Toulouse III. Hospital Universitario. Departamento de Farmacología Clínica y Neurociencia; Francia | es |
uca.affiliation | Fil: Pérez Lloret, Santiago. Pontificia Universidad Católica Argentina. Laboratorio de Clínica Farmacológica y Epidemiología; Argentina | es |
uca.affiliation | Fil: Rey, Verónica. Universidad de Toulouse III. Hospital Universitario. Departamento de Farmacología Clínica y Neurociencia; Francia | es |
uca.affiliation | Fil: Rey, Verónica. Pontificia Universidad Católica Argentina. Laboratorio de Clínica Farmacológica y Epidemiología; Argentina | es |
uca.affiliation | Fil: Pavy-Le Traon, Anne. Universidad de Toulouse III. Hospital Universitario. Departamento de Farmacología Clínica y Neurociencia; Francia | es |
uca.affiliation | Fil: Rascol, Olivier. Universidad de Toulouse III. Hospital Universitario. Departamento de Farmacología Clínica y Neurociencia; Francia | es |
uca.version | submittedVersion | es |
item.grantfulltext | open | - |
item.fulltext | With Fulltext | - |
item.languageiso639-1 | en | - |
crisitem.author.dept | Laboratorio de Neurobiología Molecular | - |
crisitem.author.dept | Consejo Nacional de Investigaciones Científicas y Técnicas | - |
crisitem.author.orcid | 0000-0001-9069-6512 | - |
crisitem.author.parentorg | Instituto de Investigaciones Biomédicas - BIOMED | - |
Aparece en las colecciones: | Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
emerging-drugs-autonomic.pdf | 288,37 kB | Adobe PDF | Visualizar/Abrir |
Visualizaciones de página(s)
140
comprobado en 30-abr-2024
Descarga(s)
477
comprobado en 30-abr-2024
Google ScholarTM
Consultar
Altmetric
Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons